Thyrocare Technologies (India) Today
| THYROCARE | 1,003 10.80 1.09% |
PerformanceSolid
| Odds Of DistressLow
|
Thyrocare Technologies is trading at 1002.80 as of the 26th of June 2025, a 1.09 percent increase since the beginning of the trading day. The stock's open price was 992.0. Thyrocare Technologies has less than a 9 % chance of experiencing financial distress in the next few years and had a solid performance during the last 90 days. The performance scores are derived for the period starting the 28th of March 2025 and ending today, the 26th of June 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Thyrocare Technologies is entity of India. It is traded as Stock on NSE exchange. The company has 52.99 M outstanding shares. More on Thyrocare Technologies Limited
Moving together with Thyrocare Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Thyrocare Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Thyrocare Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Thyrocare Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO MD | Rahul Guha | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | ||||
Thyrocare Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Thyrocare Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsThyrocare Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Thyrocare Technologies' financial leverage. It provides some insight into what part of Thyrocare Technologies' total assets is financed by creditors.
| |||||
Thyrocare Technologies Limited (THYROCARE) is traded on National Stock Exchange of India in India and employs 12 people. Thyrocare Technologies is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 52.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Thyrocare Technologies's market, we take the total number of its shares issued and multiply it by Thyrocare Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Thyrocare Technologies operates under Biotechnology sector and is part of Health Care industry. The entity has 52.99 M outstanding shares.
Thyrocare Technologies Limited has accumulated about 177.7 M in cash with 1.91 B of positive cash flow from operations.
Check Thyrocare Technologies Probability Of Bankruptcy
Ownership AllocationThyrocare Technologies shows a total of 52.99 Million outstanding shares. Thyrocare Technologies has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 71.16 % of Thyrocare Technologies outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Thyrocare Ownership Details
Thyrocare Technologies Risk Profiles
Although Thyrocare Technologies' alpha and beta are two of the key measurements used to evaluate Thyrocare Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.05 | |||
| Semi Deviation | 1.65 | |||
| Standard Deviation | 2.78 | |||
| Variance | 7.74 |
Thyrocare Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Thyrocare Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Thyrocare Technologies Corporate Management
Elected by the shareholders, the Thyrocare Technologies' board of directors comprises two types of representatives: Thyrocare Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Thyrocare. The board's role is to monitor Thyrocare Technologies' management team and ensure that shareholders' interests are well served. Thyrocare Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Thyrocare Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Preet Kaur | Vice Quality | Profile | |
| Pratik Hire | Head Relations | Profile | |
| Alok Jagnani | Chief Officer | Profile | |
| KallathiKumar | Chief Officer | Profile | |
| Brijesh Kumar | Company Officer | Profile | |
| Kapil Gupta | Strategy Manager | Profile |
Other Information on Investing in Thyrocare Stock
Thyrocare Technologies financial ratios help investors to determine whether Thyrocare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Thyrocare with respect to the benefits of owning Thyrocare Technologies security.